Class II

Drug Recall: glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60

Amerisource Health Services LLC · December 17, 2024

Reason for Recall

Failed Dissolution Specifications:

Product Description

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

2,028 units (cartons of 30 individual unit doses)

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0202-2025

Status: completed

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.